BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21393858)

  • 1. SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans.
    Liu KW; Feng H; Bachoo R; Kazlauskas A; Smith EM; Symes K; Hamilton RL; Nagane M; Nishikawa R; Hu B; Cheng SY
    J Clin Invest; 2011 Mar; 121(3):905-17. PubMed ID: 21393858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion.
    Feng H; Liu KW; Guo P; Zhang P; Cheng T; McNiven MA; Johnson GR; Hu B; Cheng SY
    Oncogene; 2012 May; 31(21):2691-702. PubMed ID: 21996738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
    Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
    Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.
    Sang Y; Hou Y; Cheng R; Zheng L; Alvarez AA; Hu B; Cheng SY; Zhang W; Li Y; Feng H
    Neuro Oncol; 2019 Nov; 21(11):1423-1435. PubMed ID: 31232447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
    Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
    Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor α.
    Feng H; Li Y; Yin Y; Zhang W; Hou Y; Zhang L; Li Z; Xie B; Gao WQ; Sarkaria JN; Raizer JJ; James CD; Parsa AT; Hu B; Cheng SY
    Neuro Oncol; 2015 Jun; 17(6):832-42. PubMed ID: 25468898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.
    Feng H; Hu B; Liu KW; Li Y; Lu X; Cheng T; Yiin JJ; Lu S; Keezer S; Fenton T; Furnari FB; Hamilton RL; Vuori K; Sarkaria JN; Nagane M; Nishikawa R; Cavenee WK; Cheng SY
    J Clin Invest; 2011 Dec; 121(12):4670-84. PubMed ID: 22080864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double minute amplification of mutant PDGF receptor α in a mouse glioma model.
    Zou H; Feng R; Huang Y; Tripodi J; Najfeld V; Tsankova NM; Jahanshahi M; Olson LE; Soriano P; Friedel RH
    Sci Rep; 2015 Feb; 5():8468. PubMed ID: 25683249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor receptor alpha in glioma: a bad seed.
    Liu KW; Hu B; Cheng SY
    Chin J Cancer; 2011 Sep; 30(9):590-602. PubMed ID: 21880180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K-mediated PDGFRα signaling regulates survival and proliferation in skeletal development through p53-dependent intracellular pathways.
    Fantauzzo KA; Soriano P
    Genes Dev; 2014 May; 28(9):1005-17. PubMed ID: 24788519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation.
    Robinson JP; VanBrocklin MW; Guilbeault AR; Signorelli DL; Brandner S; Holmen SL
    Oncogene; 2010 Jan; 29(3):335-44. PubMed ID: 19855433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ink4a/Arf loss promotes tumor recurrence following Ras inhibition.
    Vanbrocklin MW; Robinson JP; Lastwika KJ; McKinney AJ; Gach HM; Holmen SL
    Neuro Oncol; 2012 Jan; 14(1):34-42. PubMed ID: 22015595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.
    Moore LM; Holmes KM; Smith SM; Wu Y; Tchougounova E; Uhrbom L; Sawaya R; Bruner JM; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16675-9. PubMed ID: 19805356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.
    Bruggeman SW; Hulsman D; Tanger E; Buckle T; Blom M; Zevenhoven J; van Tellingen O; van Lohuizen M
    Cancer Cell; 2007 Oct; 12(4):328-41. PubMed ID: 17936558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
    Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
    Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12.
    Kumar RN; Ha JH; Radhakrishnan R; Dhanasekaran DN
    Mol Cell Biol; 2006 Jan; 26(1):50-62. PubMed ID: 16354679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.